Skip to main content
Clinical Trials/CTRI/2019/03/018026
CTRI/2019/03/018026CompletedPhase 4

Clinical utility of L-Arginine as an add on therapy in patients of hypertension

Pravara Institute Of Medical Sciences Loni0 sites180 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
180

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • All the patients of hypertension taking anti- hypertensive drugs since last sixth months
  • Adult patients between 18-60years
  • Patients of either gender
  • Patient ready to give written informed consent and willing to participate in the trial

Exclusion Criteria

  • Patient suffering from Gestational hypertension
  • Patients suffering from hypertension with Brain disorders
  • Patients with history of thyroid disorders and taking anti-epileptic medication
  • Patients on chronic medications other than anti-hypertensive drugs
  • Use of any drug that may affect nitric oxide synthesis (nitrates, CNS depressant, steroids)
  • Patients with history of Diabetes mellitus
  • Renal failure patients
  • Patient with history of ischemic heart disease, Transient ischemic attack (TIA), Stroke or peripheral arterial disease
  • Patients with history of recurrent herpes
  • Patients with history of Cancer treated with radiotherapy or chemotherapy during the last year

Investigators

Sponsor
Pravara Institute Of Medical Sciences Loni

Similar Trials